Budesonide/formoterol maintenance and reliever therapy: an effective asthma treatment option? - Wikidata - awgldk - TriplyDB

Budesonide/formoterol maintenance and reliever therapy: an effective asthma treatment option?

Budesonide/formoterol maintenance and reliever therapy: an effective asthma treatment option?

http://www.wikidata.org/entity/Q34464592

about

Addition of long-acting beta2-agonists to inhaled corticosteroids for chronic asthma in children Combination formoterol and budesonide as maintenance and reliever therapy versus current best practice (including inhaled steroid maintenance), for chronic asthma in adults and children Combination formoterol and budesonide as maintenance and reliever therapy versus combination inhaler maintenance for chronic asthma in adults and children Combination fluticasone and salmeterol versus fixed dose combination budesonide and formoterol for chronic asthma in adults and children Addition of long-acting beta-agonists to inhaled corticosteroids for chronic asthma in children Combination formoterol and inhaled steroid versus beta2-agonist as relief medication for chronic asthma in adults and children Combination formoterol and budesonide as maintenance and reliever therapy versus inhaled steroid maintenance for chronic asthma in adults and children Combination fluticasone and salmeterol versus fixed dose combination budesonide and formoterol for chronic asthma in adults and children Guidelines for diagnosis and management of bronchial asthma: Joint ICS/NCCP (I) recommendations Combination of budesonide/formoterol on demand improves asthma control by reducing exercise-induced bronchoconstriction.The airway epithelium: soldier in the fight against respiratory viruses Onset of relief of dyspnoea with budesonide/formoterol or salbutamol following methacholine-induced severe bronchoconstriction in adults with asthma: a double-blind, placebo-controlled study.Treatment of moderate to severe asthma: patient perspectives on combination inhaler therapy and implications for adherence.Real-life use of budesonide/formoterol in clinical practice: a 12-month follow-up assessment in a multi-national study of asthma patients established on single-inhaler maintenance and reliever therapy Effect of budesonide/formoterol maintenance and reliever therapy on asthma exacerbations.Enantiomeric resolution of multiple chiral centres racemates by capillary electrophoresis.Using a combination inhaler (budesonide plus formoterol) as rescue therapy improves asthma control.Canadian Thoracic Society 2012 guideline update: diagnosis and management of asthma in preschoolers, children and adults.Asthma exacerbations . 4: Prevention.Poor adherence with inhaled corticosteroids for asthma: can using a single inhaler containing budesonide and formoterol help?Satisfaction levels and asthma control amongst Malaysian asthmatic patients on budesonide/formoterol maintenance and reliever therapy: experience in a real-life setting.Therapeutic comparison of a new budesonide/formoterol pMDI with budesonide pMDI and budesonide/formoterol DPI in asthma Anti-inflammatory effects of the novel inhaled phosphodiesterase type 4 inhibitor CHF6001 on virus-inducible cytokines RETRACTED: Inhaled corticosteroids and long-acting beta-agonists in adult asthma: a winning combination in all?New approaches to managing asthma: a US perspective Canadian economic evaluation of budesonide-formoterol as maintenance and reliever treatment in patients with moderate to severe asthma The frequency of, and adherence to, single maintenance and reliever therapy instructions in asthma: a descriptive analysis.A retrospective database study comparing treatment outcomes and cost associated with choice of fixed-dose inhaled corticosteroid/long-acting beta-agonists for asthma maintenance treatment in Germany.Evaluating combination therapies for asthma: pros, cons, and comparative benefits.Differences in the pharmacodynamics of budesonide/formoterol and salmeterol/fluticasone reflect differences in their therapeutic usefulness in asthma.A comparison of budesonide/formoterol maintenance and reliever therapy vs. conventional best practice in asthma management.An official American Thoracic Society/European Respiratory Society statement: asthma control and exacerbations: standardizing endpoints for clinical asthma trials and clinical practice.Budesonide/formoterol dry powder in asthma: an option for control as maintenance and reliever therapy.Single maintenance and reliever therapy (SMART) of asthma: a critical appraisal.Budesonide/formoterol in the treatment of asthma.Patient-reported outcomes in clinical trials of inhaled asthma medications: systematic review and research needs.Budesonide/formoterol combination in COPD: a US perspective.The clinical impact of single inhaler therapy in asthma.Long-acting beta(2)-agonist and inhaled corticosteroid combination therapy for adult persistent asthma: systematic review of clinical outcomes and economic evaluation.Comparative effectiveness of long term drug treatment strategies to prevent asthma exacerbations: network meta-analysis.

P2860

Q24187686-47E6ECBE-0EF3-473D-850C-3590280D483C Q24197662-8F67C6E5-000D-4FF0-B414-78F5F63BCEFA Q24201774-0D07771F-5DB1-4113-A034-C72395631CD0 Q24234581-3269FBF3-7A11-4C15-885C-7C6EE2F5D255 Q24239922-C37CBBD4-DA01-4693-B39F-FC8D861A59DB Q24241025-CCD99A80-44CB-4B0B-8385-0E5E4CDB9040 Q24241556-A4E7F8C6-74C0-46CB-A5F8-F55B3D29E52A Q24242173-A21AAF9A-A9F0-4C93-B16E-359C2A491F89 Q28392274-512B1F3A-9E50-40DC-BD45-8178E3AF3079 Q34375152-206B3839-9659-444E-9CE9-8D6F02B9A94F Q34491598-5B451CAC-1086-4D50-A521-083FCE68C3BC Q34573003-182F996D-B7E7-4CCA-9259-832F3A52EDC8 Q34623797-2896800A-6E28-436E-85D8-C2D532DE472D Q35676597-0B64C5C9-F68D-43B1-BFD2-5120FD6D6F95 Q35894625-9C9AAC63-18B1-45F5-8C6A-69A0A59D7F81 Q35912976-453B0970-8DD9-4EA9-B6A8-71B9C150A74E Q35981019-2E5A5D42-9C9A-421A-9456-46B1E8211464 Q36027085-D9F7354E-0910-4EA3-BA2A-DF405B8BE3F6 Q36237953-79873A92-8EE9-4E7C-BFEE-D3F727E68376 Q36288427-0831525D-AEB9-4A28-B5C0-BEF340A06540 Q36422427-6C2EAD02-4933-46D5-B6B3-C7E8CAC6C682 Q36432119-EAA67394-2008-421C-B428-0341EC294E4A Q36648886-3B4481D7-93F3-4560-8D3F-B2079A9AB057 Q36805501-78B037B1-D263-49C1-8E01-C4279192F9C3 Q36823534-E989CBAD-10EA-4948-B843-E2F0EA0FB968 Q36912151-2C523931-6C1A-4CC3-B98C-A1C29D3974D4 Q37114882-7349C86C-E679-40FF-8F9F-429BA30F23DA Q37187443-0EBE0A30-E87D-4F5E-92D6-74C71385EBB3 Q37362610-E4400B65-7FA7-4F04-ABD9-3EDCCB440594 Q37362634-0603A8FE-DCCD-4B18-8D54-F6AF473BBC06 Q37428571-C47F3AA3-5A0A-483E-A432-C4B80B2F8C87 Q37522916-313E2BDB-69FB-43E8-8188-1024E2427A72 Q37678433-698E500E-FF76-4706-BE6C-3AA0AA3E68E5 Q37767986-B836F7FB-C9E0-4F73-86D6-12E126E6CE1F Q37798026-2457C7A0-3C11-4DEB-A866-5CAA312812F3 Q37800043-36ED8DAB-05C8-4AAD-83B1-715A3B844941 Q37805343-1A1A49DE-ED8A-442F-A729-C689C66F4B0D Q37976473-7F1FAA54-3D88-4903-916F-B386DC1C92A4 Q38043452-96FDFFB9-6055-45FD-8754-9F2436720B15 Q38219526-7B336090-2013-4D8D-B1C0-AC7A5520F0F4

P2860

Budesonide/formoterol maintenance and reliever therapy: an effective asthma treatment option?

http://www.wikidata.org/entity/Q34464592

description

2005 nî lūn-bûn

@nan

2005 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2005 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

2005年の論文

@ja

2005年論文

@yue

2005年論文

@zh-hant

2005年論文

@zh-hk

2005年論文

@zh-mo

2005年論文

@zh-tw

2005年论文

@wuu

name

Budesonide/formoterol maintena ...... ctive asthma treatment option?

@ast

Budesonide/formoterol maintena ...... ctive asthma treatment option?

@en

Budesonide/formoterol maintena ...... ctive asthma treatment option?

@nl

type

label

Budesonide/formoterol maintena ...... ctive asthma treatment option?

@ast

Budesonide/formoterol maintena ...... ctive asthma treatment option?

@en

Budesonide/formoterol maintena ...... ctive asthma treatment option?

@nl

prefLabel

Budesonide/formoterol maintena ...... ctive asthma treatment option?

@ast

Budesonide/formoterol maintena ...... ctive asthma treatment option?

@en

Budesonide/formoterol maintena ...... ctive asthma treatment option?

@nl

P1433

Q34464592-E4A6454C-F316-4E17-82B4-26D97119B20B

P1476

Q34464592-84467874-8164-40DA-BF4C-261FF53BC2DD

P2093

Q34464592-0F7CE156-0F70-4887-A432-6DA19BAF3924

Q34464592-5869362F-CB97-45C3-81E8-119304AF9621

Q34464592-63DB6ABD-332C-4289-B91F-4F05A806B39C

Q34464592-6FCA4C17-04DB-4DAA-B4A4-5279EDC5E612

Q34464592-D25E7592-6D38-4F04-9BC6-95C66566D152

Q34464592-DB060BDF-DD86-4332-832C-25C4F773346C

Q34464592-E5DBA622-B322-4EAC-9F0A-0F13DC7F2AC2

P304

Q34464592-595748B5-3263-4331-AD52-5A9D58A0C9C1

P31

Q34464592-378659E5-599E-47AD-8A30-A81350D7820E

P356

Q34464592-6A5E087D-A51E-47AB-8AD1-1C273151F580

P433

Q34464592-EE5AF909-3432-4FEA-AA78-6D7C7B88EE93

P478

Q34464592-8DB63EC0-7937-49E4-B853-6A7028761FEF

P50

Q34464592-BDF38A59-3F04-4C44-B153-AE053EF39662

P577

Q34464592-B594D706-7AF7-40BE-92A6-969D57361540

P5875

Q34464592-AC8CF87D-A9DC-4786-A17F-DEF32C58A605

P698

Q34464592-1E6AFF25-BB07-440B-B644-B4A9CF4E43AC

P921

Q34464592-0B62FF40-F926-4682-9EB1-6D7695059294

P356

09031936.05.00028305

P1433

European Respiratory Journal

P1476

Budesonide/formoterol maintena ...... ctive asthma treatment option?

@en

P2093

A D'Urzo

http://www.w3.org/2001/XMLSchema#string

C Vogelmeier

http://www.w3.org/2001/XMLSchema#string

I Naya

http://www.w3.org/2001/XMLSchema#string

J M Merino

http://www.w3.org/2001/XMLSchema#string

M Jaspal

http://www.w3.org/2001/XMLSchema#string

R Pauwels

http://www.w3.org/2001/XMLSchema#string

S Boutet

http://www.w3.org/2001/XMLSchema#string

P304

819-828

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1183/09031936.05.00028305

http://www.w3.org/2001/XMLSchema#string

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

26

http://www.w3.org/2001/XMLSchema#string

P50

P577

2005-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

7503373

http://www.w3.org/2001/XMLSchema#string

P698

16264042

http://www.w3.org/2001/XMLSchema#string

P921